BAJAJ BROKING

Notification
No new Notification messages
Inventurus Knowledge Solutions IPO is Open!
Apply for the Inventurus Knowledge Solutions IPO through UPI in just minutes.
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.
NSE BSE
sms lifesciences (i) ltd stock

SMS LIFESCIENCES (I) LTD Share Price

1197 7.30 (0.61%)
Dec 13 2024 03:14 PM Pharmaceuticals NSE: SMSLIFE

SMS LIFESCIENCES (I) LTD Share Price Update

As of the latest trading session, SMS LIFESCIENCES (I) LTD share price is currently at 1197, which is up by 7.30 from its previous closing. Today, the stock has fluctuated between 1188.95 and 1197.00. Over the past year, SMS LIFESCIENCES (I) LTD has achieved a return of 129.15 %. In the last month alone, the return has been 3.26 %. Read More...

SMS LIFESCIENCES (I) LTD Performance

Day Range

Low1188.95 High1197.00
1197.00

52 Week Range

Low 487.05 High 1749.65
1197.00

SMS LIFESCIENCES (I) LTD Share Price

21555

540679

SMSLIFE

img img img img
No Data Available

Open Price

1197.00

Prev. Close

1189.70

Volume (Shares)

643.00

Total traded value

7.69

Upper Circuit

1213.45

Lower Circuit

1165.90

Note: The current prices & values are delayed, Login to your account for live updates.

SMS LIFESCIENCES (I) LTD Fundamentals


(Standalone)

Market Cap (Cr) 361.88
PE Ratio (TTM) 16.70
Book Value / Share 621.85
Beta 0.85
ROE 7.68%
EPS (TTM) 71.83
Dividend Yield 0.12%
Net Profit Qtr (Cr) 6.01

SMS LIFESCIENCES (I) LTD Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition

Revenue

Net income

Particulars SEP 2024 (Values in Cr)
Revenue 78.50
Operating Expense 71.19
Net Profit 6.01
Net Profit Margin (%) 7.65
Earnings Per Share (EPS) 19.87
EBITDA 13.05
Effective Tax Rate (%) 29.78
Particulars JUN 2024 (Values in Cr)
Revenue 86.57
Operating Expense 77.46
Net Profit 6.46
Net Profit Margin (%) 7.46
Earnings Per Share (EPS) 21.37
EBITDA 14.20
Effective Tax Rate (%) 32.28
Particulars MAR 2024 (Values in Cr)
Revenue 86.37
Operating Expense 80.74
Net Profit 5.93
Net Profit Margin (%) 6.86
Earnings Per Share (EPS) 19.63
EBITDA 13.09
Effective Tax Rate (%) 24.90
Particulars DEC 2023 (Values in Cr)
Revenue 71.23
Operating Expense 66.79
Net Profit 3.31
Net Profit Margin (%) 4.64
Earnings Per Share (EPS) 10.96
EBITDA 9.66
Effective Tax Rate (%) 34.71
Particulars SEP 2023 (Values in Cr)
Revenue 67.84
Operating Expense 63.40
Net Profit 3.12
Net Profit Margin (%) 4.59
Earnings Per Share (EPS) 10.31
EBITDA 9.80
Effective Tax Rate (%) 34.80
Particulars MAR 2024 (Values in Cr)
Revenue 300.00
Operating Expense 284.71
Net Profit 13.07
Net Profit Margin (%) 4.35
Earnings Per Share (EPS) 43.22
EBITDA 38.26
Effective Tax Rate (%) 31.65
Particulars MAR 2023 (Values in Cr)
Revenue 315.24
Operating Expense 302.09
Net Profit 13.22
Net Profit Margin (%) 4.19
Earnings Per Share (EPS) 43.72
EBITDA 31.63
Effective Tax Rate (%) 28.03
Particulars MAR 2022 (Values in Cr)
Revenue 345.63
Operating Expense 326.88
Net Profit 25.38
Net Profit Margin (%) 7.34
Earnings Per Share (EPS) 83.95
EBITDA 45.60
Effective Tax Rate (%) 23.04
Particulars MAR 2021 (Values in Cr)
Revenue 260.26
Operating Expense 242.23
Net Profit 13.17
Net Profit Margin (%) 5.06
Earnings Per Share (EPS) 43.56
EBITDA 31.06
Effective Tax Rate (%) 31.98
Particulars MAR 2020 (Values in Cr)
Revenue 256.92
Operating Expense 245.47
Net Profit 9.15
Net Profit Margin (%) 3.56
Earnings Per Share (EPS) 30.26
EBITDA 25.67
Effective Tax Rate (%) 31.40
Particulars MAR 2024 (Values in Cr)
Book Value / Share 584.84
ROE % 3.67
ROCE % 7.24
Total Debt to Total Equity 0.58
EBITDA Margin 10.34
Particulars MAR 2023 (Values in Cr)
Book Value / Share 557.71
ROE % 6.12
ROCE % 8.31
Total Debt to Total Equity 0.56
EBITDA Margin 8.91
Particulars MAR 2022 (Values in Cr)
Book Value / Share 503.53
ROE % 11.26
ROCE % 11.95
Total Debt to Total Equity 0.51
EBITDA Margin 9.31
Particulars MAR 2021 (Values in Cr)
Book Value / Share 427.40
ROE % 11.07
ROCE % 12.53
Total Debt to Total Equity 0.53
EBITDA Margin 10.85
Particulars MAR 2020 (Values in Cr)
Book Value / Share 382.80
ROE % 9.17
ROCE % 11.70
Total Debt to Total Equity 0.50
EBITDA Margin 9.53
Particulars MAR 2024 (Values in Cr)
Book Value / Share 582.90
ROE % 7.68
ROCE % 10.68
Total Debt to Total Equity 0.53
EBITDA Margin 11.67
Particulars MAR 2023 (Values in Cr)
Book Value / Share 542.55
ROE % 7.20
ROCE % 8.85
Total Debt to Total Equity 0.47
EBITDA Margin 8.25
Particulars MAR 2022 (Values in Cr)
Book Value / Share 500.16
ROE % 11.47
ROCE % 12.54
Total Debt to Total Equity 0.39
EBITDA Margin 8.67
Particulars MAR 2021 (Values in Cr)
Book Value / Share 417.88
ROE % 10.99
ROCE % 13.83
Total Debt to Total Equity 0.40
EBITDA Margin 10.85
Particulars MAR 2020 (Values in Cr)
Book Value / Share 374.61
ROE % 8.39
ROCE % 11.52
Total Debt to Total Equity 0.45
EBITDA Margin 9.09
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 1.49
Total Assets 390.51
Total Liabilities 390.51
Total Equity 193.63
Share Outstanding 3023287
Price to Book Ratio 1.16
Return on Assets (%) 2.32
Return on Capital (%) 3.12
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 4.41
Total Assets 394.89
Total Liabilities 394.89
Total Equity 188.21
Share Outstanding 3023287
Price to Book Ratio 0.96
Return on Assets (%) 2.90
Return on Capital (%) 4
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 4.39
Total Assets 356.74
Total Liabilities 356.74
Total Equity 164.92
Share Outstanding 3023287
Price to Book Ratio 1.39
Return on Assets (%) 7.09
Return on Capital (%) 10.46
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 11.06
Total Assets 302.29
Total Liabilities 302.29
Total Equity 129.21
Share Outstanding 3023287
Price to Book Ratio 1.18
Return on Assets (%) 4.48
Return on Capital (%) 7.01
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 7.59
Total Assets 252.83
Total Liabilities 252.83
Total Equity 115.73
Share Outstanding 3023287
Price to Book Ratio 0.47
Return on Assets (%) 4.02
Return on Capital (%) 5.87
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 1.25
Total Assets 347.37
Total Liabilities 347.37
Total Equity 176.22
Share Outstanding 3023287
Price to Book Ratio 1.16
Return on Assets (%) 3.76
Return on Capital (%) 4.93
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 0.95
Total Assets 337.38
Total Liabilities 337.38
Total Equity 164.02
Share Outstanding 3023287
Price to Book Ratio 0.96
Return on Assets (%) 3.91
Return on Capital (%) 5.3
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 2.13
Total Assets 312.00
Total Liabilities 312.00
Total Equity 151.21
Share Outstanding 3023287
Price to Book Ratio 1.39
Return on Assets (%) 8.13
Return on Capital (%) 12.03
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 8.90
Total Assets 271.74
Total Liabilities 271.74
Total Equity 126.33
Share Outstanding 3023287
Price to Book Ratio 1.18
Return on Assets (%) 4.84
Return on Capital (%) 7.71
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 2.30
Total Assets 228.94
Total Liabilities 228.94
Total Equity 113.25
Share Outstanding 3023287
Price to Book Ratio 0.47
Return on Assets (%) 3.99
Return on Capital (%) 5.79
Particulars MAR 2024 (Values in Cr)
Net Income 9.84
Cash from Operations 27.30
Cash from Investing -18.45
Cash from Financing -6.56
Net change in Cash -0.70
Free Cash Flow 48.17
Particulars MAR 2023 (Values in Cr)
Net Income 14.24
Cash from Operations 17.95
Cash from Investing -31.29
Cash from Financing 16.88
Net change in Cash 0.29
Free Cash Flow 66.50
Particulars MAR 2022 (Values in Cr)
Net Income 20.03
Cash from Operations -3.53
Cash from Investing -7.14
Cash from Financing 10.83
Net change in Cash -7.55
Free Cash Flow 47.61
Particulars MAR 2021 (Values in Cr)
Net Income 19.56
Cash from Operations 40.10
Cash from Investing -26.23
Cash from Financing -2.54
Net change in Cash 6.38
Free Cash Flow 75.66
Particulars MAR 2020 (Values in Cr)
Net Income 14.66
Cash from Operations 17.60
Cash from Investing -27.01
Cash from Financing 12.44
Net change in Cash -0.02
Free Cash Flow 40.95
Particulars MAR 2024 (Values in Cr)
Net Income 19.11
Cash from Operations 17.75
Cash from Investing -13.74
Cash from Financing -0.81
Net change in Cash 0.18
Free Cash Flow 31.47
Particulars MAR 2023 (Values in Cr)
Net Income 16.02
Cash from Operations 8.07
Cash from Investing -27.96
Cash from Financing 22.59
Net change in Cash -0.79
Free Cash Flow 41.98
Particulars MAR 2022 (Values in Cr)
Net Income 20.28
Cash from Operations -7.09
Cash from Investing -7.48
Cash from Financing 14.62
Net change in Cash -7.51
Free Cash Flow 17.86
Particulars MAR 2021 (Values in Cr)
Net Income 19.35
Cash from Operations 26.22
Cash from Investing -5.94
Cash from Financing -7.86
Net change in Cash 7.80
Free Cash Flow 39.54
Particulars MAR 2020 (Values in Cr)
Net Income 13.33
Cash from Operations 16.77
Cash from Investing -13.27
Cash from Financing -2.05
Net change in Cash -1.37
Free Cash Flow 30.05
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 64.13 36.86 3.50 491.45 37.54 / 77.70
BLISS GVS PHARMA LTD 175.85 22.01 1.83 1852.87 92.25 / 179.65
CIPLA LTD 1447.35 25.32 4.12 116889.80 1192.85 / 1702.00
FERMENTA BIOTECH LIMITED 403.70 140.17 4.09 1188.13 145.00 / 440.00
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 64.13 55.77 10.90 491.45 37.54 / 77.70
AMRUTAJAN HEALTH LTD 749.90 45.61 7.28 2168.01 556.05 / 861.40
ASTRAZENECA PHARMA IND LT 6603.60 128.25 24.30 16509.00 4050.15 / 8139.85
BLISS GVS PHARMA LTD 175.85 22.93 1.80 1852.87 92.25 / 179.65

Technicals

  • EMA & SMA
  • Resistance and Support
  • Price Change Analysis
- redarrow -
red-green-graph indicator
Bullish Moving Averages -
Bearish Moving Averages -
  • 5 Days 1173.30
  • 26 Days 1180.60
  • 10 Days 1172.10
  • 50 Days 1258.40
  • 12 Days 1168.70
  • 100 Days 1235.90
  • 20 Days 1151.80
  • 200 Days 646.10
1189.70
PIVOT
First Resistance 1189.70
Second Resistance 1189.70
Third Resistance 1189.70
First Support 1189.70
Second Support 1189.70
Third Support 1189.70
RSI 49.91
MACD -11.88
Commodity Channel Index (CCI) 86.61
ADX 43.94
Williams % R -11.66

Over 1 Month

down

3.26

Over 3 Months

down

-25.82

Over 6 Months

down

48.78

Over 1 Year

down

129.15

Over 3 Years

down

12.49

Over 5 Years

down

35.21

SMS LIFESCIENCES (I) LTD Future

Future: Price

25 May
0 100 200 300 400 500 600

Discount/Premium

25 May
0 1 2 3 4 5 6 7

Active Calls

25 May
0 500 1000 1500 2000 2500 3000

Active Puts

25 Jul
0 500 1000 1500 2000 2500

SMS LIFESCIENCES (I) LTD Shareholding Pattern

  • Shareholding Summary
  • Historical Promotor Holding
  • Historical MF Holding
  • Historical FII Holding

Holding

Public
28.57
Promoter Holdings
71.4
FII
0.02
DII
0.0
Promoter Shares(Pledge Percentage)
0.0
Name Category Shares Shares%
Annapurna Talluri Shareholding of Promoter and Promoter Group 742436.0 24.56
Tvvsn Murthy Shareholding of Promoter and Promoter Group 480034.0 15.88
Tvvsn Murthy (huf) (karta - Mr.tvvsn Murthy) Shareholding of Promoter and Promoter Group 241190.0 7.98
Ramesh Babu Potluri Shareholding of Promoter and Promoter Group 240190.0 7.94
Venkata Praveen Talluri Shareholding of Promoter and Promoter Group 132157.0 4.37
Hima Bindu Potluri Shareholding of Promoter and Promoter Group 83333.0 2.76
Sudeepthi Gopineedi Shareholding of Promoter and Promoter Group 78899.0 2.61
Trilok Potluri Shareholding of Promoter and Promoter Group 78141.0 2.58
Vamsi Krishna Potluri Shareholding of Promoter and Promoter Group 73234.0 2.42
Harita Projects Private Public Shareholding 47508.0 1.57
Bharadhwajan Jaganathan Velamur Public Shareholding 31150.0 1.03
Potluri Infra Projects Llp Shareholding of Promoter and Promoter Group 8000.0 0.26
Sukumari Koneru Shareholding of Promoter and Promoter Group 714.0 0.02
Venkata Chaitanya Gopineedi Shareholding of Promoter and Promoter Group 361.0 0.01
Pixalot Labs Private Limited Shareholding of Promoter and Promoter Group 0.0 0.0
Potluri Laboratories Private Limited Shareholding of Promoter and Promoter Group 0.0 0.0
Rajeswara Rao Gopineedi Shareholding of Promoter and Promoter Group 100.0 0.0

SMS LIFESCIENCES (I) LTD

  • Dividend
  • Bonus
  • Split
Ex-Date Dividend Amt. Dividend Type Record Date Instrument Type
2023-09-22 1.5 Final 2023-09-23 Equity shares 2022-09-22 1.5 Final 2022-09-24 Equity shares 2021-09-20 1.5 Final 2021-09-21 Equity shares 2019-09-19 1.5 Final 2019-09-23 Equity shares
Ex-Date Ex-Bonus Ratio
Ex-Date Old FV NEW FV Record Date

Learn More About Stocks

About SMS LIFESCIENCES (I) LTD

Read More
  • Management structure
  • Board of directors
  • Committees of the board of directors

Companies Owned by SMS LIFESCIENCES (I) LTD

We have something for everyone

Explore More Investment Options

Stocks

Secure and enhance your financial future today

investment-card-icon

IPOs

Your gateway to future financial opportunities

investment-card-icon

MTF

Explore Buy Now Pay Later and boost your capital by up to 4x  

investment-card-icon

US Stocks

Discover opportunities to invest in elite FAANG stocks

investment-card-icon

Frequently Asked Questions

What is the Share Price of SMS Lifesciences India Ltd?

Answer Field

The share price of SMS Lifesciences India Ltd for NSE is ₹ 1197 and for BSE is ₹ 1199.3.

What is the Market Cap of SMS Lifesciences India Ltd?

Answer Field

The market cap of SMS Lifesciences India Ltd for NSE is ₹ 3,61.88 Cr. and for BSE is ₹ 3,62.58 Cr. as of now.

What is the 52 Week High and Low of SMS Lifesciences India Ltd?

Answer Field

The 52 Week High and Low of SMS Lifesciences India Ltd for NSE is ₹ 1749.65 and ₹ 487.05 and for BSE is ₹ 1747.85 and ₹ 488.05.

How to Buy SMS Lifesciences India Ltd share?

Answer Field

You can trade in SMS Lifesciences India Ltd shares with Bajaj Broking by opening a Demat Account.

What is 1 year return for SMS Lifesciences India Ltd?

Answer Field

The 1 year returns on the stock has been 129.15%.

What is the Current Share Price of SMS Lifesciences India Ltd?

Answer Field

SMS Lifesciences India Ltd share price is for NSE ₹ 1197 & for BSE ₹ 1199.3 as on Dec 13 2024 03:14 PM.

What is the Market Cap of SMS Lifesciences India Ltd Share?

Answer Field

The market cap of SMS Lifesciences India Ltd for NSE ₹ 3,61.88 & for BSE ₹ 3,62.58 as on Dec 13 2024 03:14 PM.

What is the P/E Ratio of SMS Lifesciences India Ltd Share?

Answer Field

As on Dec 13 2024 03:14 PM the price-to-earnings (PE) ratio for SMS Lifesciences India Ltd share is 16.70.

What is the PB ratio of SMS Lifesciences India Ltd Share?

Answer Field

As on Dec 13 2024 03:14 PM, the price-to-book (PB) ratio for SMS Lifesciences India Ltd share is 621.85.

How to Buy SMS Lifesciences India Ltd Share?

Answer Field

You can trade in SMS Lifesciences India Ltd shares with Bajaj Broking by opening a demat account.

How to Buy SMS Lifesciences India Ltd Share on Bajaj Broking App?

Answer Field

To buy SMS Lifesciences India Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “SMS Lifesciences India Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

Our Secure Trading Platforms

Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading

Bajaj Broking App Download

8 Lacs+ Users

icon-with-text

4.4+ App Rating

icon-with-text

4 Languages

icon-with-text

₹4700+ Cr MTF Book

icon-with-text
loader